Summary
The hyperplasia and hyperaemia of the thyreoidea of rats caused by thiouracil treatment can be largely avoided by simultaneous doses of vitamin-A methylether.
References
E. B. Astwood, J. Pharmac. exp. Ther.78, 79 (1943).
C. Wegelin, Helv. med. acta I, H. 3 (1948).
O. Isler, W. Huber, A. Ronco undR. Kofler, Barell Fest-schrift 1946, S. 31; Exper.2, 31 (1946).
J. Abelin, Münch. med. Wschr.1, 36 (1937).
D. P. Sadhu undS. Brody, Am. J. Phys.149, No. 2, 400 (1947).
Th. v. Fellenberg undF. Brüter, Biochem. Z.253, 42 (1932).
B. Sure undK. Buchanam, J. Nutr.13, 513 (1937).
F. Steffen undT. Zois, Arch. exp. Path. Pharm.189, 75 (1938).
E. Schulze undG. Hundhausen, Arch. exp. Path. Pharm.192, 43 (1939).
K. Fellinger undO. Hochstedt, Wiener klin. Wschr. 1339 (1936).
J. Jacobi undH. Pomp, Klin. Wschr. 873 (1938).
W. Thiele, Münch. med. Wschr. Nr. 32, 881 (1941).
H. Wendt, Med. Klinik32, 27 (1936).
K. Voit, Münch. med. Wschr. Nr. 41 (1937).
H. E. Dietrich, Münch. med. Wschr. Nr. 8. (1936).
K. Neidhardt, Therapie der Gegenwart Nr. 7 (1937).
S. Simkins, J. clin. Endocrinol.7, 574 (1947).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Studer, A. Hemmung des Thiouracilkropfes der Ratte durch synthetischen Vitamin-A-Methyläther. Experientia 4, 232–233 (1948). https://doi.org/10.1007/BF02155378
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02155378